Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Drug Interaction with Cyclosporine and Tacrolimus
NCT03083782Phase 1Completed
- Sponsor
- Thomas Jefferson University
- Start
- Apr 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban in venous thromboembolism (VTE) (3 arms), sponsored by Thomas Jefferson University. Primary endpoints: Apixaban area under the plasma concentration curve between 0 and 72 hours and Apixaban peak plasma concentration. Started Apr 2017; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03083782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03083782.